Yu F - Search Results

1

Development of small-molecule inhibitors against hantaviruses.

Deng X, Tian S, Yu Z, Wang L, Liang R, Li Y, Xiang R, Jiang S, Ying T, Yu F. Deng X, et al. Among authors: yu f, yu z. Microbes Infect. 2020 Jul-Aug;22(6-7):272-277. doi: 10.1016/j.micinf.2020.05.011. Epub 2020 May 20. Microbes Infect. 2020. PMID: 32445882 Free article. Review.

2

Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocket.

Yu F, Lu L, Du L, Zhu X, Debnath AK, Jiang S. Yu F, et al. Viruses. 2013 Jan 11;5(1):127-49. doi: 10.3390/v5010127. Viruses. 2013. PMID: 23344560 Free PMC article. Review.

3

Small molecule fusion inhibitors: design, synthesis and biological evaluation of (Z)-3-(5-(3-benzyl-4-oxo-2-thioxothiazolidinylidene)methyl)-N-(3-carboxy-4-hydroxy)phenyl-2,5-dimethylpyrroles and related derivatives targeting HIV-1 gp41.

He XY, Lu L, Qiu J, Zou P, Yu F, Jiang XK, Li L, Jiang S, Liu S, Xie L. He XY, et al. Among authors: yu f. Bioorg Med Chem. 2013 Dec 1;21(23):7539-48. doi: 10.1016/j.bmc.2013.04.046. Epub 2013 Apr 26. Bioorg Med Chem. 2013. PMID: 23673219

4

Tactics used by HIV-1 to evade host innate, adaptive, and intrinsic immunities.

Lu L, Yu F, DU LY, Xu W, Jiang SB. Lu L, et al. Among authors: yu f. Chin Med J (Engl). 2013 Jun;126(12):2374-9. Chin Med J (Engl). 2013. PMID: 23786957 Review.

5

An engineered HIV-1 gp41 trimeric coiled coil with increased stability and anti-HIV-1 activity: implication for developing anti-HIV microbicides.

Tong P, Lu Z, Chen X, Wang Q, Yu F, Zou P, Yu X, Li Y, Lu L, Chen YH, Jiang S. Tong P, et al. Among authors: yu f, yu x. J Antimicrob Chemother. 2013 Nov;68(11):2533-44. doi: 10.1093/jac/dkt230. Epub 2013 Jun 21. J Antimicrob Chemother. 2013. PMID: 23794600

6

A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV.

Zhao G, Du L, Ma C, Li Y, Li L, Poon VK, Wang L, Yu F, Zheng BJ, Jiang S, Zhou Y. Zhao G, et al. Among authors: yu f. Virol J. 2013 Aug 26;10:266. doi: 10.1186/1743-422X-10-266. Virol J. 2013. PMID: 23978242 Free PMC article.

7

F(ab')2 fragment of a gp41 NHR-trimer-induced IgM monoclonal antibody neutralizes HIV-1 infection and blocks viral fusion by targeting the conserved gp41 pocket.

Lu L, Wei M, Chen Y, Xiong W, Yu F, Qi Z, Jiang S, Pan C. Lu L, et al. Among authors: yu f. Microbes Infect. 2013 Nov;15(13):887-94. doi: 10.1016/j.micinf.2013.10.001. Epub 2013 Oct 17. Microbes Infect. 2013. PMID: 24141089 Free article.

8

ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer.

Yu F, Lu L, Liu Q, Yu X, Wang L, He E, Zou P, Du L, Sanders RW, Liu S, Jiang S. Yu F, et al. Among authors: yu x. Biochim Biophys Acta. 2014 May;1838(5):1296-305. doi: 10.1016/j.bbamem.2013.12.022. Epub 2014 Jan 3. Biochim Biophys Acta. 2014. PMID: 24388952 Free article.

9

Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor.

Lu L, Liu Q, Zhu Y, Chan KH, Qin L, Li Y, Wang Q, Chan JF, Du L, Yu F, Ma C, Ye S, Yuen KY, Zhang R, Jiang S. Lu L, et al. Among authors: yu f. Nat Commun. 2014;5:3067. doi: 10.1038/ncomms4067. Nat Commun. 2014. PMID: 24473083 Free PMC article.

10

Artificial peptides conjugated with cholesterol and pocket-specific small molecules potently inhibit infection by laboratory-adapted and primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains.

Wang C, Shi W, Cai L, Lu L, Yu F, Wang Q, Jiang X, Xu X, Wang K, Xu L, Jiang S, Liu K. Wang C, et al. Among authors: yu f. J Antimicrob Chemother. 2014 Jun;69(6):1537-45. doi: 10.1093/jac/dku010. Epub 2014 Feb 4. J Antimicrob Chemother. 2014. PMID: 24500189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,333 results

Search Page